Task: Answer the multiple choice question.
Question: Which drug exhibits a 16.623\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a.) COc1ccc(NC(=S)NCc2ccccc2OC)c(OC)c1
b.) COCCCNc1nc2ccccc2nc1NS(=O)(=O)c1ccc(C)cc1
c.) C=CCn1c(SCC(=O)Nc2ccc3c(c2)OCO3)nnc1-c1ccccc1O
d.) C=C(C)CN(CC)CCC(=O)Nc1ccc(OC)cc1OC.Cl
e.) CC(Sc1nnnn1C1CC1)C(=O)N1CC(=O)Nc2ccccc21
Answer: e. CC(Sc1nnnn1C1CC1)C(=O)N1CC(=O)Nc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(Sc1nnnn1C1CC1)C(=O)N1CC(=O)Nc2ccccc21
CC(Sc1nnnn1C1CC1)C(=O)N1CC(=O)Nc2ccccc21
4-[2-(1-cyclopropyltetrazol-5-yl)sulfanylpropanoyl]-1,3-dihydroquinoxalin-2-one